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ABSTRACT
Background
We previously reported a significant association between higher ultraviolet radiation exposure before diagnosis and greater survival with melanoma in a population-based study in Connecticut. We sought to evaluate the hypothesis that sun exposure prior to diagnosis was associated with greater survival in a larger, international population-based study with more detailed exposure information.
Methods
We conducted a multi-center, international population-based study in four countries -Australia, Italy, Canada and the United States -with 3,578 cases of melanoma with an average of 7.4 years of follow-up. Measures of sun exposure included sunburn, intermittent exposure, hours of holiday sun exposure, hours of waterrelated outdoor activities, ambient UVB dose, histological solar elastosis and season of diagnosis.
Results
Results were not strongly supportive of the earlier hypothesis. Having had any sunburn in one year within 10 years of diagnosis was inversely associated with survival; solar elastosis -a measure of lifetime cumulative exposure -was not. Additionally, none of the intermittent exposure measures -water related activities and sunny holidays -were associated with melanoma-specific survival. Estimated ambient UVB dose was not associated with survival. 
INTRODUCTION
Ultraviolet radiation exposure (UVR) is the major environmental risk factor for the development of melanoma (1) with intermittent UVR exposure, including sunburn, generally the measure of sun exposure most strongly associated with the development of melanoma (2) (3) . In a Connecticut population-based study of 650 melanoma cases followed for an average of five years, Berwick et al. (4) reported that several measures of UVR prior to the diagnosis of melanoma were inversely associated with mortality from melanoma, suggesting that something about sun exposure, possibly its role in Vitamin D production, was limiting cancer progression. Subsequently, Newton-Bishop and colleagues in a UK study of 872 melanoma patients (5) reported that serum vitamin D levels were higher among those with better overall survival, and Rosso and colleagues in a European study of 260 melanoma patients (6) found that melanoma patients with more sunny vacations prior to diagnosis had better melanoma-specific survival.
Laboratory studies have shown that vitamin D suppresses tumor proliferation (7) and suggest that increased vitamin D levels might keep a melanoma "in check". To test the hypothesis that increased sun exposure prior to diagnosis is associated with improved survival from melanoma, we evaluated measures of solar UVR exposure prior to diagnosis in 3,578 incident melanoma patients in the Genes, Environment and Melanoma study (GEM), an international, population-based study (8).
MATERIALS AND ETHODS
Subjects. A detailed description of the methods used in this study is available elsewhere (9). Briefly, this multicenter, international population-based study was conducted in four countries through eight population-based tumor registries---in The overall participation rate was 54 percent for individuals completing all aspects of the study and submitting a DNA sample. Data Collection. A structured questionnaire administered by telephone assessed basic demographics, phenotypic characteristics, family history of cancer, recreational and occupational sun exposure at each decade of life, sunbed use, changes in sunrelated behavior after a melanoma diagnosis, and a lifetime residential history. Nevi on the back were self-assessed using a set of photos and by reference to charts showing different patterns of nevi and freckles as previously described (2, 9). UVR Exposure Measures. We evaluated effects on survival of measures of UVR exposure in various periods before diagnosis.
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Sunburns. Individuals reported whether they had been burned severely enough to have pain or blisters for two or more days in a specified year in the 10 years before diagnosis. This was coded as "once or more" or "never". Solar Elastosis. Solar elastosis, an indicator of sun exposure accumulated over a lifetime (10), was evaluated on histopathological slide review as absent or present.
Slides from 2,781 (78%) subjects were reviewed by expert dermatopathologists (LF, KB, PG) to standardize pathologic criteria and add parameters that community pathology laboratories often do not report, such as solar elastosis. Inter-reviewer reliability for solar elastosis was assessed as very good (Kappa = 0.65).
Intermittent Sun Exposure. In a previous GEM analysis, two variables were considered to represent intermittent sun exposure -hours of holiday sun exposure in a place sunnier than usual residence and hours of water-related outdoor activities (2). single primaries or the most recent melanoma for those with multiple primaries was the outcome. Those who died of other causes or who were still alive at follow up were censored in this analysis.
Age at diagnosis, sex, recruitment center, education level, and anatomic site were potential confounders of the association of sun exposure measures and melanoma survival. We found that there was no difference in effects of sun exposure measures and survival by primary status and therefore included both single and multiple primary melanomas in analyses in order to improve precision and included an indicator variable for primary status in all models. Kricker et al. (11) previously reported that there was no survival difference between multiple and single primaries in GEM. A timedependent covariate was used for the 96 patients who developed a second primary during the study follow up period. Pigmentary characteristics, prior history of nonmelanoma skin cancer and family history of melanoma were assessed but found not to be potential confounders of sun exposure measures in relation to survival. Stratified analyses were conducted to determine if any effect of sun exposure measures on risk of death from melanoma was modified by MC1R status (with or without "red hair color" variants D84E, R151C, R160W, and D294H), ability to tan (good and poor) and propensity to sunburn (high and low). Likelihood ratio tests for heterogeneity were used to evaluate significance of any apparent effect modification. Tests for linear trend were performed for ordered categorical variables. All tests were two-sided and P < 0.05 was considered statistically significant. All data were analyzed using SAS 9.3 (Cary, NC). 
RESULTS
Of the 3,578 eligible individuals diagnosed with melanoma in this study (2, 007 males and 1,571 females), 563 died by the end of follow up (15.7%): 255 (7.1%) from melanoma and 308 (8.6%) from other causes.
Survival analyses are presented as baseline models, with hazard ratios adjusted for center, age, sex, primary status and the time-dependent covariate, and as fully adjusted models, which included the above variables as well as others significantly associated with survival: educational level, and anatomic site.
Clinical and Host Characteristics and Melanoma-Specific Survival. Anticipated associations for host and clinical characteristics were seen (Table 1) . Primary status was not associated with hazard of death from melanoma in the fully adjusted model.
Women had a lower risk of dying from melanoma in both the baseline model (P < 0.001) and the fully adjusted model (P = 0.0002). The hazard of death increased with increasing age (fully adjusted HR 1.02 for each year of age, 95% CI =1.01 to 1.03, P <0.0001). Melanomas on the arms were at lowest risk for poor survival relative to melanoma of the head and neck (fully adjusted HR 0.47, 95% CI = 0.31 to 0.71, P = 0.003). Relative to superficial spreading melanoma, the fully adjusted HR for lentigo maligna melanoma was decreased (HR 0.57, 95% CI = 0.33 to 0.98, P = 0.04).
Breslow thickness (fully adjusted HR 13.79, 95% CI =9.12 to 20.84, for thickness of 4.00 mm or higher relative to thickness of less than 1.00 mm) was strongly and significantly associated with poor prognosis (P < 0.001). Similar to most other studies, those with more education had a significantly reduced hazard of dying from melanoma (fully 
Recent Sun Exposure
We found a reduced HR of melanoma death with one or more sunburns in a year in the decade before diagnosis (fully adjusted HR 0.27, 95% CI = 0.09, 0.85, P = 0.03, Table 2 ). Other sun exposure variables in the decade before diagnosis, including holiday sun hours in a place sunnier than usual residence and hours of water-related activities and estimated UVB dose, and season of diagnosis were not significantly associated with survival from melanoma in either the baseline or the fully adjusted models.
Early Life Sun Exposure
We found a significant trend for increasing melanoma mortality with increasing UVB dose at age 10, (fully adjusted HR 1.49, 95% CI = 0.97, 2.30, P = 0.03) for the highest quartile compared to the lowest. Other sun exposure variables in early life were not significantly associated with survival from melanoma (Table 3) .
Lifetime Average Annual Sun Exposure
None of the lifetime cumulative or annual average sun exposure measures were associated either positively or negatively with melanoma-specific survival (Table 4) . 
water related activities and estimated solar UVB dose were also not significantly associated with melanoma-specific survival (Table 4) Tables 1-3) . It is important to note that because this study is population-based, it includes many individuals with very thin melanomas and hence high overall survival. Such population-based studies are critical for public health recommendations, but any particular effects of lifestyle on survival would be most relevant for the more selected group of people whose melanoma characteristics place them at a higher likelihood of mortality from melanoma.
In the Rosso et al. (6) study, the population from Turin, Italy, was quite small.
The major variable associated with improved survival with melanoma was number of holidays to sunny places; it is possible that this variable is confounded with socioeconomic status, which has been found to be inversely associated with hazard of death from melanoma in three studies (13) (14) (15) . exposure on overall survival; however, this study was not designed to evaluate deaths other than melanoma.
Several limitations deserve note, particularly the potential for misclassification in recalled sun exposure. Because the "dose" information relies on reported hours of sun exposure multiplied by the ambient exposure, there is the potential for misclassification that is likely non-directional and would bias results to the null. Additionally, although sunburn is likely subject to recall bias (16) , the fact that sunburn represents overexposure to the sun, whereas exposure to high ambient levels of UV is modified by behaviors and phenotype, may make the single finding that sunburn prior to diagnosis is "protective" more salient. Caution is necessary in interpreting that finding due to the very small number of deaths in the group experiencing sunburn (n=4). Misclassification could also result from differences among centers in non-UV sun related behaviors that might affect mortality in comparison to previous single center studies where more uniform non-UV behaviors factors might be more uniform.
Another concern lies with the use of death certificates for verification of mortality as death certificates are sometimes misclassified (17) . Each of the centers in this study had high quality identification of deaths, using death certification, such as the National Death Index in the United States and Australia and the Provincial Cancer Registries in Canada. In Italy, deaths were verified by linking to the municipal rosters. If in fact a patient died from a metastasis from his melanoma but was classified as dying from another cancer, such as lung cancer, then our statistical power will have been reduced. Furthermore, it is noted that deaths from melanoma continue to occur over a relatively (18) and one did not (19) ; both were from Australia.
Our study's strengths include the large number of participants, the variety of latitudes, the relatively long follow up, a reliable sun exposure questionnaire (20) (21) , the ability to control for confounders, and the extensive pathologic review of cases.
In conclusion, this study provides only weak evidence that high levels of sun exposure prior to diagnosis have a benefit for melanoma survival. 
